Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

Monthly Merger Review Snapshot No Photo Available

Matthew Perlman

Enforcers opened high stakes court proceedings against Meta Platforms and Google for monopolization claims that could force the tech g... (more story)

Trans Care In Court: DOJ Memo, Ohio Ban And Insurer Loss No Photo Available

Gianna Ferrarin

Ohio's highest court is allowing the state to enforce a law banning the use of puberty blockers and hormones for minors seeking to med... (more story)

This Week's Healthcare Earnings: Tariffs Galore No Photo Available

Yeji Jesse Lee

Tariffs were, unsurprisingly, a major theme on investor calls this past week, as around a dozen healthcare companies released their qu... (more story)